These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 1220986)

  • 1. [Pharmacology of anti-arrhythmic agents (author's transl)].
    Hergueta G
    Folia Clin Int (Barc); 1975 Dec; 25(12):661-73. PubMed ID: 1220986
    [No Abstract]   [Full Text] [Related]  

  • 2. [Endocavitary study of Lorcainide (author's transl)].
    Depaepe A; Sartieaux A; De Mey D
    Rev Med Brux; 1980 Mar; 1(3):157-9. PubMed ID: 7466015
    [No Abstract]   [Full Text] [Related]  

  • 3. [Mechanism of paroxysmal supraventricular tachycardia (author's transl)].
    González R
    Rev Med Chil; 1981 Mar; 109(3):246-51. PubMed ID: 7280410
    [No Abstract]   [Full Text] [Related]  

  • 4. [Anti-arrhythmic agents. 2. Special anti-arrhythmic effect, known drug interactions].
    Weiss-Simon C; Spangenberg G; Michel D
    Fortschr Med; 1980 Apr; 98(15):569-72. PubMed ID: 7390368
    [No Abstract]   [Full Text] [Related]  

  • 5. [The electrophysiological effects of disopyramide (author's transl)].
    Ponsonnaille J; Marcheix JC; Gras H
    Ann Cardiol Angeiol (Paris); 1977; 26(2):135-9. PubMed ID: 900834
    [No Abstract]   [Full Text] [Related]  

  • 6. [Mode of action of antiarrhythmic drugs (author's transl)].
    Sano T
    Kokyu To Junkan; 1974 Apr; 22(4):321-6. PubMed ID: 4603686
    [No Abstract]   [Full Text] [Related]  

  • 7. [On the anti-arrhythmic activity of serpentine and its effect on the heart conduction system].
    Gendenshteĭn EI; Mikhaĭlenko LA
    Farmakol Toksikol; 1965; 28(1):42-6. PubMed ID: 5845040
    [No Abstract]   [Full Text] [Related]  

  • 8. [Anti-arrhythmic drugs and heart conduction].
    Furlanello F
    G Clin Med; 1973 Jul; 54(7):382-406. PubMed ID: 4779853
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of mexiletine on the excitability and vulnerability of the dog ventricle (author's transl)].
    Márquez Montes J; Vera Almazán A; Esteve Alderete JJ; Puente Rodero B; Montero C; Castillo-Olivares JL
    Arch Farmacol Toxicol; 1981 Dec; 7(3):307-18. PubMed ID: 7337470
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical development of an anti-arrhythmic. Human electrophysiology].
    Libersa C; Caron J; Lekieffre J
    Therapie; 1986; 41(2):87-93. PubMed ID: 3726795
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical pharmacology of anti-arrhythmia agents].
    Rahn KH
    Verh Dtsch Ges Inn Med; 1975; 81():111-9. PubMed ID: 1229410
    [No Abstract]   [Full Text] [Related]  

  • 12. [Stimulation, stimulus conduction and myocardial excitability of the human heart under oxyfedrin therapy of bradycardic dysrhythmias (author's transl)].
    Diewitz M
    Med Klin; 1974 May; 69(18):806-13. PubMed ID: 4151986
    [No Abstract]   [Full Text] [Related]  

  • 13. [Profile of a new anti-arrhythmic agent: propafenon. I. Electrophysiologic characterization].
    Disertori M; Vergara G; Dal Forno P; Inama G; Furlanello F
    Boll Soc Ital Cardiol; 1981; 26(1):75-85. PubMed ID: 7340862
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical pharmacology of anti-arrhythmia agents].
    Azanza Perea JR; Honorato Pérez JM; Cuena Boy R
    Rev Med Univ Navarra; 1984 Mar; 28(1):37-43. PubMed ID: 6147005
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect of magnesium sulphate on the supernormal phase of myocardial excitability (author's transl)].
    Critelli G; Maione S; Adinolfi L; Ferro G; Perticone F; Condorelli M
    Ann Cardiol Angeiol (Paris); 1977 Oct; 26(5):407-11. PubMed ID: 907304
    [No Abstract]   [Full Text] [Related]  

  • 16. [Mechanisms of cellular action of anti-arrhythmia agents].
    Sebag C; Motté G
    Coeur Med Interne; 1978; 17(4):508-19. PubMed ID: 737994
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of anti-arrhythmia drugs on the heart conduction system].
    Walczak F
    Kardiol Pol; 1992; 36(2):92-6. PubMed ID: 1583832
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical indications of different drugs for refractory arrhythmias (author's transl)].
    Leclercq JF; Coumel P
    Ther Umsch; 1982 Feb; 39(2):128-36. PubMed ID: 7071785
    [No Abstract]   [Full Text] [Related]  

  • 19. [Antiarrhythmic agents and atrioventricular conduction].
    Knippel M; Rovelli F
    G Ital Cardiol; 1972; 2(1):184. PubMed ID: 5012012
    [No Abstract]   [Full Text] [Related]  

  • 20. [Pharmacological study of (naphtyloxy-1)4-hydroxy-3 butyramidoxime chlorhydrate or LL 1530. Anti-arrhythmic action].
    Duteil J; Nadaud J; Henry M; Assous E; Gombert R
    Therapie; 1973; 28(4):703-20. PubMed ID: 4793689
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.